You would like to read
- dunnhumby India expands leadership team with deeper engineering capabilities
- Short Term Course on Artificial Intelligence for teachers commences with great zeal & enthusiasm at MIT Centre for future skills excellence
- Skill Development Course on Foundations of Modern Machine Learning launched at IHub-Data, IIIT Hyderabad
- iHub-Data, IIIT Hyderabad opens applications for skill development course on foundations of modern machine learning
- Nupur Recyclers IPO closes day 3 with over 41.37X subscription
Bengaluru (Karnataka) [India], February 9 (ANI/NewsVoir): West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug and healthcare products, recently announced its partnership with TECHIN - a Technology Innovation Foundation of IIT Palakkad which focuses on assisting innovation and incubation for budding entrepreneurs, to build a MedTech Research Center of Excellence.
The aim of building a distinctive MedTech Research Center of Excellence is to enable access to healthcare and medical technology by developing an ecosystem of academia, hospitals and the industry to promote local entrepreneurship. To achieve this objective, West's medical expertise with IIT's unique incubation model will be combined to advance research and development in medical technology.
West will work with IIT Palakkad's TECHIN in the area of medical technology. The engagement will be carried out by West's Digital Technology Center (DTC) in Bengaluru which will be directly working with TECHIN's team throughout this partnership. To support the start-ups in the program, West will be providing a noncommercial version of its 'medical device connectivity platform' to support the development of connected med-tech equipment. Additionally, West will mentor and may fund start-ups through the MedTech Research Center of Excellence.
IIT Palakkad, situated in the foothills of Western Ghats is very well incorporated in the industrial ecosystem of Coimbatore and Palakkad, making it an ideal institute for partnership. Furthermore, it offers a vast network of successful entrepreneurs from the region including PAN IIT alumni, cutting-edge research facilities and technical expertise of the faculty.
Speaking on the partnership, Anoop Madhusudanan, Vice President of Digital Marketing & Digital Platforms at West said, "The intersection of medicine and technology is yet to be explored to its depth and has transformative abilities in providing access to healthcare and ease of patient care. At West, we believe in continuously pushing the boundaries of innovation to provide the best healthcare and medicinal support to the patient. And with this partnership, we envision moving closer to our goal."
"The partnership with West will enable us to make advancements in medical technology. We expect researchers and innovators to take advantage of TECHIN's unique incubation model and West's expertise in medical devices and health technology to accelerate development of technologies that'll ultimately benefit the society. We are grateful to West for coming forward to set up this Center at TECHIN and are looking forward to working with them in making MedTech Research Center of Excellence successful in the country," said P.B Sunil Kumar, Director IIT Palakkad and Chairman TECHIN.
Contact for West MedTech Research Center of Excellence: medtech@techin-iitpkd.org.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)
DISCLAIMER
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
